Rare Cancers Australia

Radio Rare

Business EN ↓ Odcinki: 53

Radio Rare is a podcast where we share the stories of those in and around the rare and less common cancer community. Being diagnosed with a rare cancer doesn’t mean you’re alone. Radio Rare will dive into the human stories of the rare cancer experience, the innovation and the advocacy. Addressing the feeling of isolation experienced by so many, we look to create a close community of those affected by rare and less common cancers. Produced by Rare Cancers Australia

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: bit.ly

Autor

Rare Cancers Australia

Kategoria

Business

Strona podcastu

bit.ly

Ostatni odcinek

17 kwi 2025

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Paul Cross, the Australian Healthcare system 13.04.2020 28:03

Radio Rare episode two! Paul Cross joins us for a passionate discussion about the approval process of new therapies. Paul is a publisher and the founder of the Biopharma Dispatch. We cover a wide range of topics from the PBS (Pharmaceutical Benefit Scheme) and HTA (Health Technology Assessment), to Australia's role in the global market and Paul's views on investing in new therapies to give people...

Richard Vines, life as a cancer carer 06.04.2020 41:46

Welcome to the first episode of season 1! Dr Emily Isham sits down with Rare Cancers Australia CEO Richard Vines. Richard discusses his role as a carer over the past 30 years, the NFP industry and how RCA was born.

Trailer 31.03.2020 3:10

Rare Cancer patients quite simply don't fit into the current health system. Radio Rare is a podcast that looks deeper into the issues that hold rare cancers back from having parity with the access, treatment pathways, timely diagnosis and overall survival common cancers experience. We talk to patients, their families, experts and game-changers on the current state of Rare.